# INTRODUCTION {#sec-introduction}

*Provide background information about the drug being analyzed and the role of the population PK analysis in the overall clinical development program. Highlight the relevance of the drugâ€™s pharmacokinetic characteristics to the model development. Describe how the analysis aligns with the objectives of the clinical development plan and any special considerations pertinent to the study population or methodology.*